88.3
Eledon Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
59.5
FY23:
56.1
FY24:
144
FY25:
136
(positive)
Change from FY21 to FY25
millions USD
FY21:
82.2
FY22:
33.3
FY23:
32.9
FY24:
33.7
FY25:
33.3
Total assets
Change from FY21 to FY25
millions USD
FY21:
171
FY22:
92.8
FY23:
89.1
FY24:
177
FY25:
169
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.40
FY22:
6.48
FY23:
3.90
FY24:
11.6
FY25:
18.3
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.15
FY22:
2.14
FY23:
78.0
FY24:
47.7
FY25:
13.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
164
FY22:
84.2
FY23:
−48.5
FY24:
62.4
FY25:
81.1
Total liabilities & equity
Change from FY21 to FY22
millions USD
FY21:
171
FY22:
92.8
FY23:
–
FY24:
–
FY25:
–
All amounts in millions USD